Related Experiment Video
Updated: Aug 13, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Sepsis and antibiotics: When should we deploy a parachute?
Sharon Einav1, Marc Leone2, Ignacio Martin-Loeches3
1Hebrew University School of Medicine, Jerusalem, Israel; Intensive Care Unit of the Shaare Zedek Medical Center, Jerusalem, Israel.
Physicians face pressure to administer antibiotics rapidly for sepsis, balancing patient outcomes against the rise of antibiotic resistance. This article explores strategies to aid clinical decision-making in uncertain sepsis cases.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Clinical Decision Support
Background:
- Sepsis and septic shock guidelines mandate antimicrobial therapy within one hour of diagnosis, driven by evidence linking early treatment to improved outcomes.
- Physicians are challenged to rapidly diagnose sepsis and initiate antibiotics, often with uncertain diagnoses, leading to potential overuse.
- Antibiotic overuse contributes significantly to the global health crisis of multidrug-resistant bacteria.
Discussion:
- This article examines the dilemma faced by front-line physicians, who are criticized for both delayed and unnecessary antibiotic use.
- It explores the complex clinical scenario of balancing timely sepsis treatment with antimicrobial stewardship.
- The discussion focuses on providing practical options to support bedside clinical judgment.
Key Insights:
- Early antimicrobial administration in sepsis is crucial for patient survival.
- The rise of multidrug-resistant organisms necessitates careful antibiotic stewardship.
- Clinical decision-making in uncertain sepsis requires tools to mitigate risks of both under- and over-treatment.
Outlook:
- Developing and implementing effective clinical decision support tools for sepsis diagnosis and antibiotic initiation is essential.
- Further research into diagnostic biomarkers and risk stratification models can aid clinicians.
- Promoting antimicrobial stewardship programs remains critical in combating resistance.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Asepsis
Urine Studies II: Urine Culture and Sensitivity Test
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Hand hygiene
Hand washing...

